Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created new fertile ground for acceleration of adoption that shows no sign of stopping.
Get your copy of Curia's latest white paper for insights on:
- The inherent benefits of PFS and how they relate to the delivery of drugs such as biologics and vaccines
- How SARS-CoV-2 could be fueling an explosive increase in PFS demand
- Why a partnership with a flexible CDMO is the key to success
